Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Markman

Showing results (171-180 of 1,622) with videos related to

Pageof 163
Sort By:
Journal of Experimental Therapeutics & Oncology|October 27, 2004
Improving the toxicity profile of chemotherapy for advanced ovarian cancer: a potential role for CT-2103Maurie Markman
Journal of Cancer Research and Clinical Oncology|May 20, 2004
Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future managementMaurie Markman
Current Oncology Reports|October 16, 2004
Recent reminders of why the gold standard for clinical research in oncology is the well-designed and conducted randomized phase III trialMaurie Markman
Cleveland Clinic Journal of Medicine|November 1, 1994
Realistic goals of cancer therapy: effective and humane careM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
30th annual meeting of the American Society of Clinical Oncology. Dallas, Texas, May 1994M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Partial responses to antineoplastic drug therapy: what do they mean?M Markman
Current Oncology Reports|October 14, 2005
A "snapshot" of an ovarian cancer clinical practice: evidence for viewing the malignancy as a "chronic disease"Maurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Screening for ovarian cancer: is it appropriate?M Markman
Disease-A-Month : DM|July 1, 1984
Newer techniques in cancer chemotherapyM Markman
JAMA|August 6, 1982
Pretreatment peripheral blood counts in small-cell carcinoma of the lungM Markman
Pageof 163

Showing results (171-180 of 1,622) with videos related to

Sort By:
Pageof 163
Journal of Experimental Therapeutics & Oncology|October 27, 2004
Improving the toxicity profile of chemotherapy for advanced ovarian cancer: a potential role for CT-2103Maurie Markman
Journal of Cancer Research and Clinical Oncology|May 20, 2004
Experience with platinum-based and high-dose chemotherapy in patients with gestational trophoblastic disease: possible implications for future managementMaurie Markman
Current Oncology Reports|October 16, 2004
Recent reminders of why the gold standard for clinical research in oncology is the well-designed and conducted randomized phase III trialMaurie Markman
Cleveland Clinic Journal of Medicine|November 1, 1994
Realistic goals of cancer therapy: effective and humane careM Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
30th annual meeting of the American Society of Clinical Oncology. Dallas, Texas, May 1994M Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1992
Partial responses to antineoplastic drug therapy: what do they mean?M Markman
Current Oncology Reports|October 14, 2005
A "snapshot" of an ovarian cancer clinical practice: evidence for viewing the malignancy as a "chronic disease"Maurie Markman
Journal of Cancer Research and Clinical Oncology|January 1, 1994
Screening for ovarian cancer: is it appropriate?M Markman
Disease-A-Month : DM|July 1, 1984
Newer techniques in cancer chemotherapyM Markman
JAMA|August 6, 1982
Pretreatment peripheral blood counts in small-cell carcinoma of the lungM Markman
Pageof 163